Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 2.3.2022Actavis Group PTC ehf. (ACT-5)0171APioglitazone Actavis 45 mg tablety (tbl 28x45 mg (blis.Al/Al))15.4.2022R
 2.3.2022Megafyt Pharma s. r. o. (MEY)76434Čajová zmes pri tráviacich ťažkostiach (spc 20x1,5 g (vre.záparové))2.3.2022O
 2.3.2022Mundipharma Gesellschaft m.b.H. (MUP-A-2)94310MST Continus 30 mg (tbl mod 60x30 mg (blis.Al/PVDC/PVC))2.3.2022O
 2.3.2022Mundipharma Gesellschaft m.b.H. (MUP-A-2)94310MST Continus 30 mg (tbl mod 60x30 mg (blis.Al/PVDC/PVC))21.2.2022R
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)27549ACCUZIDE 10 (tbl flm 30x10 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)27551ACCUZIDE 10 (tbl flm 100x10 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)64788ACCUZIDE 20 (tbl flm 30x20 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)64790ACCUZIDE 20 (tbl flm 100x20 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 1.3.2022Zentiva, k.s. (ZNT-1)01076Ophthalmo-Framykoin (ung oph 1x5 g (tuba Al))15.3.2022R
 1.3.2022Zentiva, k.s. (ZNT-1)10381Azitrox 250 (tbl flm 6x250 mg (blis.PVC/Al))3.3.2022O
 1.3.2022Zentiva, k.s. (ZNT-1)2513DZetovar 10 mg/40 mg tablety (tbl 90x10 mg/40 mg (blis.OPA/Al/PVC))1.3.2022R
 1.3.2022Zentiva, k.s. (ZNT-1)2516DZetovar 10 mg/80 mg tablety (tbl 30x10 mg/80 mg (blis.OPA/Al/PVC))3.3.2022O
 1.3.2022Zentiva, k.s. (ZNT-1)41864Lozap H (tbl flm 90 (blis. PVC/PVDC/Al))15.3.2022R
 1.3.2022Zentiva, k.s. (ZNT-1)6451ATezeo HCT 80 mg/25 mg (tbl 28x80 mg/25 mg (blis.OPA/Al/PVC/Al))1.3.2022R
 1.3.2022Zentiva, k.s. (ZNT-1)75428CHLORPROTHIXEN 50 LÉČIVA (tbl flm 30x50 mg (blis.PVC/Al))15.3.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)